Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis

Journal of Investigative Dermatology

Volumn 116, Issue 5, 2001, Pages 713-720

  Kuroda, Kei ^a,b   Sapadin, Allen ^a   Shoji, Toru ^a   Fleischmajer, Raul ^a   Lebwohl, Mark ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Shimotsuga General Hospital   (Japan)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; HUMAN; HUMAN CELL; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PSORIASIS; SKIN DISEASE;

EID: 0035012596     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2001.01316.x     Document Type: Article

References (38)

1. Asahara T, Chen D, Takahashi T, et al: Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 83:233-240, 1998
2. Baker B, Fry L: The immunology of psoriasis. Br J Dermatol 126:1-9, 1992
3. Birk PE, Grimm PC: Rapid nonradioactive in situ hybridization for interleukin-2 mRNA with riboprobes generated using ehe polymerase chain reaction. J Immunol Meth 167:83-89, 1994
4. Bouck N, Stellmach V, Hsu S: How tumors become angiogenic. Adv Cancer Res 69:135-174, 1996
5. Braverman IM, Sibley BA: Role of the microcirculation in the treatment and pathogenesis of psoriasis. J Invest Dermatol 78:12-17, 1982
6. Davis S, Aldrich TH, Jones PF, et al: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169, 1996
7. Detmar M, Brown LF, Claffey KP, et al: Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med 180:1141-1146, 1994
8. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, Breitman ML: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909, 1994
9. Esgleyes-Ribot T, Chandraratana RA, Lew-Kaya DA, Sefton J, Duvic M: Response of psoriasis to a new topical retinoid, AGN 190168. J Am Acad Dermatol 30:581-590, 1994
10. Gale NW, Yancopoulos GD: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055-1066, 1999
11. Hecker D, Worsley J, Yueh G, Kuroda K, Lebwohl M: Interactions between tazarotene and ultraviolet light. J Am Acad Dermatol 41:927-930, 1999
12. Herrmann K, Bohme HJ: Effect of cytokines and growth factors on fibroblast activity. In: LapiËre CM, Krieg T, eds. Connective Tissue Diseases of the Skin. New York:Marcel Dekker, 1993:pp 295-313
13. Holash J, Maisonpierre PC, Compton D, et al: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998, 1999
14. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W: Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8:529-532, 1998
15. Kuroda K, Shinkai H: Downregulation of decorin expression in dermal fibroblasts by interleukin-4. Arch Dermatol Res 289:476-480, 1997
16. Kuroda K, Tsukifuji R, Shinkai H: Increased expression of heat-shock protein 47 is associated with overproduction of type I procollagen in systemic sclerosis skin fibroblasts. J Invest Dermatol 111:1023-1028, 1998
17. Kuroda K, Okamoto O, Shinkai H: Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor beta, interleukin-4, and matrix collagen. J Invest Dermatol 112:706-710, 1999
18. Kwak HJ, So JN, Lee SJ, Kim I, Koh GY: Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448:249-253, 1999
19. Macdonald-Hull S, Goodfield M, Wood EJ, Cunliffe WJ: Active and inactive edge of psoriasis plaques: identification by tracing and investigation by laser-doppler flowmetry and immunocytochemical techniques. J Invest Dermatol 92:782-785, 1989
20. Maisonpierre PC, Suri C, Jones PF, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997
21. Malhotra R, Stenn KS, Fernandez LA, Braverman IM: Angiogenic properties of normal and psoriatic skin associate with epidermis, not dermis. Lab Invest 61:162-165, 1989
22. Mandriota SJ, Pepper MS: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 83:852-859, 1998
23. Mordovtsev VN, Albanova VI: Morphology of skin microvasculature in psoriasis. Am J Dermatopathol 11:33-42, 1989
24. + perivascular dendritic cells. J Invest Dermatol 96:333-340, 1991
25. Otani A, Takagi H, Oh H, Koyama S, Matsumura M, Honda Y: Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40:1912-20, 1999
26. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, Sessa WC: Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79:213-223, 1999
27. Peters KG, Coogan A, Berry D, et al: Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis. Br J Cancer 77:51-56, 1998
28. Ragaz A, Ackerman AB: Evolution maturation, and regression of lesions of psoriasis. Am J Dermatopathol 1:199-214, 1979
29. Sato TN, Tozawa Y, Deutsch U, et al: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74, 1995
30. Stratmann A, Risau W, Plate KH: Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am J Pathol 153:1459-1466, 1998
31. Suri C, Jones PF, Patan S, et al: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180, 1996
32. Suri C, McClain J, Thurston G, et al: Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471, 1998
33. Vallat VP, Gilleaudeau P, Battat 1, et al: PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 180:283-296, 1994
34. Weinstein GD, McCullough JL, Ross PA: Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol 85:579-583, 1985
35. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, Isner JM: Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2. J Biol Chem 273:18514-18521, 1998
36. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG: Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81:567-574, 1997
37. Yaguchi H, Tsuboi R, Ueki R, Ogawa H: Immunohistochemical localization of basic fibroblast growth factor in skin diseases. Acta Derm Venereol (Stockh) 73:81-83, 1993
38. Zagzag D, Hooper A, Friedlander DR, et al: In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 159:391-400, 1999